Status:

RECRUITING

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

Lead Sponsor:

The University of Texas Health Science Center, Houston

Conditions:

Psychosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that recei...

Eligibility Criteria

Inclusion

  • primary diagnoses of schizophrenia spectrum disorder or mood disorder with psychotic features, as determined by the treatment team or record review
  • capacity to consent to the study as determined by licensed psychologists ( or the primary attending psychiatrist
  • reported sleep dysfunction which will be determined by a subthreshold or more severe score ≥ 8 on the Insomnia Severity Index (ISI), and/or report experiencing nightmares at least once a week.

Exclusion

  • primary substance- or medical-induced psychosis
  • intellectual and developmental disabilities
  • neurodegenerative cognitive disorders
  • implanted devices (e.g., Pacemakers)
  • on one-to-one supervision or 15-minute safety checks for suicidality or aggression
  • patients with roommates that are on 15-minute checks to minimize impact on study participants' awakenings

Key Trial Info

Start Date :

March 5 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06194344

Start Date

March 5 2024

End Date

June 1 2026

Last Update

July 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030